October, 2025
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
HbA1c Reduction, Not Weight Loss, Drives GLP-1RA Heart Benefits
Oct 7, 2025, 15:04

HbA1c Reduction, Not Weight Loss, Drives GLP-1RA Heart Benefits

 

Emma Harutyunyan, Endocrinologist at Yeolyan Hematology and Oncology Center, shared a post by Daisuke Yabe on LinkedIn:

”HbA1c reduction, not bodyweight change, was significantly and proportionally associated with MACE risk reduction.

HbA1c lowering may serve as a useful surrogate for the cardiovascular improvements associated with GLP-1RAs in type 2 diabetes.”

Quoting Daisuke Yabe‘s post:

”FYI”

Title: Cardiovascular risk reduction with glucagon-like peptide-1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta-regression analysis incorporating FLOW and SOUL trials

Authors: Masashi Hasebe, Chen-Yang Su, Yamato Keidai, Hiroto Minamino, Daisuke Yabe, Nobuya Inagaki, Satoshi Yoshiji

HbA1c

Stay updated with Hemostasis Today.